Improving preventive medicine for diabetes and hypertension
Effects of Facilitating On-Site Recordings of Office Blood Pressure, Height, and Weight on Preventive Medicine - A Pragmatic Cluster Randomized Trial
This study tests if a new way of keeping track of patients' blood pressure, height, and weight in clinics can help doctors find more cases of high blood pressure and diabetes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 800 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Trial ID | NCT06406192 on ClinicalTrials.gov |
What this trial studies
This study evaluates the FOR-Care model's effectiveness in enhancing the documentation of blood pressure, height, and weight in outpatient clinics. Conducted as a cluster randomized trial at National Taiwan University Hospital, clinics will either implement the FOR-Care model or continue with standard care. The study aims to improve the diagnosis of undiagnosed hypertension and diabetes by assessing the impact of better documentation practices. Outcomes will be measured at 12 and 24 weeks to determine the effectiveness of the intervention.
Who should consider this trial
Good fit: Ideal candidates for this study are adults visiting outpatient clinics who may be at risk for undiagnosed hypertension or diabetes.
Not a fit: Patients under 18, those with active catastrophic illnesses, terminal malignancies, or recent major cardiac events may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to earlier diagnosis and better management of hypertension and diabetes, improving patient outcomes.
How similar studies have performed: Other studies have shown success with similar preventive medicine approaches, indicating potential for positive outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Cluster-level inclusion criteria: * clinic sessions with at least 15 patients, but fewer than 40 patients Cluster-level exclusion criteria: * travel, hospice, vaccination, or health examination clinics * special-appointed clinics Patient-level exclusion criteria * patients aged less than 18 * patients with active catastrophic illness or terminal malignancies * patients with major adverse cardiac events within 3 months before the index dates
Where this trial is running
Taipei
- National Taiwan University Hospital — Taipei, Taiwan (Recruiting)
Study contacts
- Study coordinator: Chien-Hsieh Chiang, MD, MPH, PhD
- Email: jiansie@gmail.com
- Phone: +886-972651864
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.